前收市價 | 0.7000 |
開市 | 0.6900 |
買盤 | 0.6759 x 100 |
賣出價 | 0.6886 x 100 |
今日波幅 | 0.6800 - 0.7264 |
52 週波幅 | 0.5000 - 4.6700 |
成交量 | |
平均成交量 | 629,290 |
市值 | 37.409M |
Beta 值 (5 年,每月) | 0.70 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.1900 |
業績公佈日 | 2024年5月13日 - 2024年5月17日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 5.23 |
Are you feeling good about the stock market? You should. The market continued to show strength in early 2024, which is all the more reason to rid your portfolio of F-rated stocks. When the stock market’s this strong, it’s no time to consolidate your positions around bottom-dwellers at bargain prices. This is a time to capitalize on the market’s momentum and look for stocks that are already strong. So far in 2024, the Dow Jones Industrial Average is up more than 2%, topping 38,000. The Nasdaq Com
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
Cara (CARA) delivered earnings and revenue surprises of -3.51% and 28.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?